Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates…
Biotechnology
US, Marlborough [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Phio Pharmaceuticals Corp. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDPhio Pharmaceuticals Corp. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Phio Pharmaceuticals Corp..
If you want to see a demo, head over to the financial segments of AAPL